The Federal Reserve's decision to pause rate hikes has sent mixed signals across equity and bond markets. Here's how savvy investors are repositioning their portfolios.
The largest longitudinal study of semaglutide users has uncovered benefits and risks that go far beyond weight loss, reshaping how doctors prescribe these blockbuster drugs.
Beyond the marketing, what do the benchmarks and real-world tests reveal about the capabilities of OpenAI's latest model? We ran 200 hours of tests to find out.
Join thousands of readers who get the best of Finance, Health, Technology, News, and Entertainment delivered to their inbox every week. Free, curated, no spam.
No spam, ever. Unsubscribe with one click at any time.
